PMID- 35781650 OWN - NLM STAT- MEDLINE DCOM- 20230201 LR - 20230202 IS - 1573-4919 (Electronic) IS - 0300-8177 (Linking) VI - 478 IP - 2 DP - 2023 Feb TI - Pluronic F127-liposome-encapsulated curcumin activates Nrf2/Keap1 signaling pathway to promote cell migration of HaCaT cells. PG - 241-247 LID - 10.1007/s11010-022-04481-6 [doi] AB - Curcumin (CUR) is an extract of Curcuma longa Linn., which has various pharmacological activities. The instability, low water solubility and bioavailability of CUR greatly limit its clinical application. This work prepared Pluronic F127-liposome-encapsulated curcumin (CUR-LIP-F127) and explored its functional role in wound healing. Liposome-encapsulated curcumin (CUR-LIP) and CUR-LIP-F127 were prepared. Human keratinocyte cell line (HaCaT) was treated with CUR, Pluronic F127-liposome (LIP-F127) and CUR-LIP-F127, or combined with ML385 (Nrf2 inhibitor). The expression of mRNAs and proteins was detected by quantitative real-time PCR and western blotting. MTT and wound healing assays were performed to detect cell viability and migration. CUR, LIP-F127 and CUR-LIP-F127 all had no influence on cell viability of HaCaT cells. CUR-LIP-F127 treatment significantly accelerated cell migration and enhanced the expression of nuclear factor erythroid-related factor 2 (Nrf2) and kelch-like erythroid cell-derived protein 1 (Keap1) in HaCaT cells with respect to CUR or LIP-F127 treatment. ML385 treatment impaired CUR-LIP-F127-mediated promotion of migration and up-regulation of Nrf2 and Keap1 in HaCaT cells. This work demonstrated that CUR-LIP-F127 activated Nrf2/Keap1 signaling pathway to promote migration of HaCaT cells, suggesting that CUR-LIP-F127 may contribute to wound healing. CI - (c) 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature. FAU - Zhou, Quan AU - Zhou Q AD - Department of Emergency, The First Hospital of Hunan University of Chinese MedicineYuhua DistrictHunan Province, No. 95, Shaoshan Middle Road, Changsha, 410000, People's Republic of China. FAU - Cai, Xu AU - Cai X AD - Department of Orthopaedic, The First Hospital of Hunan University of Chinese Medicine, Hunan Province, Changsha, 410000, People's Republic of China. FAU - Huang, Ying AU - Huang Y AD - Department of Neurosurgery, Guangdong Province, Shenzhen Sami International Medical Center, Shenzhen, 518038, People's Republic of China. FAU - Zhou, Youliang AU - Zhou Y AUID- ORCID: 0000-0002-9063-3906 AD - Department of Emergency, The First Hospital of Hunan University of Chinese MedicineYuhua DistrictHunan Province, No. 95, Shaoshan Middle Road, Changsha, 410000, People's Republic of China. zhouyouliang0125@163.com. LA - eng GR - 202104101005/Hunan Provincial Health Commission/ GR - 2021227/Hunan Administration of traditional Chinese Medicine/ PT - Journal Article DEP - 20220704 PL - Netherlands TA - Mol Cell Biochem JT - Molecular and cellular biochemistry JID - 0364456 RN - IT942ZTH98 (Curcumin) RN - 0 (Liposomes) RN - 9038-95-3 (UCON 50-HB-5100) RN - 106392-12-5 (Poloxamer) RN - 0 (NF-E2-Related Factor 2) RN - 0 (Kelch-Like ECH-Associated Protein 1) RN - 0 (KEAP1 protein, human) SB - IM MH - Humans MH - *Curcumin/pharmacology MH - Liposomes MH - Poloxamer MH - NF-E2-Related Factor 2 MH - HaCaT Cells MH - Kelch-Like ECH-Associated Protein 1 MH - Signal Transduction OTO - NOTNLM OT - Curcumin OT - Liposome OT - Migration OT - Nrf2/Keap1 signaling pathway OT - Pluronic F127 OT - Wound healing EDAT- 2022/07/06 06:00 MHDA- 2023/02/02 06:00 CRDT- 2022/07/05 09:21 PHST- 2022/02/10 00:00 [received] PHST- 2022/05/13 00:00 [accepted] PHST- 2022/07/06 06:00 [pubmed] PHST- 2023/02/02 06:00 [medline] PHST- 2022/07/05 09:21 [entrez] AID - 10.1007/s11010-022-04481-6 [pii] AID - 10.1007/s11010-022-04481-6 [doi] PST - ppublish SO - Mol Cell Biochem. 2023 Feb;478(2):241-247. doi: 10.1007/s11010-022-04481-6. Epub 2022 Jul 4.